Eugene Liu - Shanghai Henlius Biotech, Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 9 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

AWT020: a Novel Fusion Protein Harnessing PD-1 Blockade and Selective IL-2 Cis-activation for Enhanced Anti-Tumor Immunity and Diminished Toxicity

Fan Ye, Jianing Huang, Xiaoli Cheng, Shih Chieh Chen, Fang Huang, Wen-Chin Huang, Botong Hua,Ella Li,Jenny Jiang, Hanna Lin,Matthew Siegel,Eric Liao, Ji Wang,Bella Yue, Wenli Shi, Yanghua Xu, Xin Wang, Jiaming Wang, Yuyuan Yan, Honglin He,Eugene Liu,Binfeng Lu,Ziyang Zhong

Frontiers in immunology (2025): 1537466-1537466

Cited0Views0WOSBibtex

Exenokine-2: a half-life extended no--il-2 with improved preclinical pharmacological properties supports first-in-human clinical development

Lili Cheng,Fan Ye,Sandra Chen,Jianing Huang,Jenny Jiang,Henry He,Shirley Shi,Mingxing Yang, Qiang Fu,Ark Xia, Yudan Hong, Wang Xin,Karen Yuan,Hongchuan Liu,Hui Feng,Eugene Liu,Ziyang Zhong

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022): A1123-A1123

Cited0Views0Bibtex

1081 Exenokine-2: a Half-Life Extended No-Α-il-2 with Improved Preclinical Pharmacological Properties Supports First-in-human Clinical Development

Lili Cheng,Fan Ye,Sandra Chen,Jianing Huang,Jenny Jiang,Henry He,Shirley Shi,Mingxing Yang, Qiang Fu,Ark Xia, Yudan Hong, Wang Xin,Karen Yuan,Hongchuan Liu,Hui Feng,Eugene Liu,Ziyang Zhong

Regular and Young Investigator Award Abstracts (2022)

Cited0Views0Bibtex

Distinguishing Features of a Novel Humanized Anti-Egfr Monoclonal Antibody Based on Cetuximab with Superior Antitumor Efficacy

Pei-Hua Lin,Chi-Ling Tseng, Yun-Chih Cheng,Chieh-Hsin Ho, Shih Chieh Chen,Yanling Wang,Eugene Liu,Hassan Issafras,Weidong Jiang

EXPERT OPINION ON BIOLOGICAL THERAPY（2021）

Cited5Views0WOSBibtex

Structural Basis of HLX10 PD-1 Receptor Recognition, a Promising Anti-Pd-1 Antibody Clinical Candidate for Cancer Immunotherapy

Hassan Issafras,Shilong Fan,Chi-Ling Tseng, Yunchih Cheng,Peihua Lin, Lisa Xiao, Yun-Ju Huang, Chih-Hsiang Tu,Ya-Chin Hsiao,Min Li, Yen-Hsiao Chen,Chien-Hsin Ho,Ou Li,Yanling Wang,Sandra Chen, Zhenyu Ji, Eric Zhang,Yi-Ting Mao,Eugene Liu,Shumin Yang,Weidong Jiang

wos（2021）

Cited23Views0WOSBibtex

FRI0086 CHINA-MANUFACTURED ADALIMUMAB BIOSIMILAR, HLX03, DEMONSTRATED PHARMACOKINETIC EQUIVALENCE AND COMPARABLE SAFETY TO REFERENCE ADALIMUMAB

Jixun Sun,Guiling Chen,Min Wu, Yiwen Han, He Gao,Tianli Zhang,Xinjun Guo,Xin Zhang,Eugene Liu,Alvin Luk,Weidong Jiang,Scott Liu,Katherine Chai,Yanhua Ding

ANNALS OF THE RHEUMATIC DISEASES（2019）

Cited4Views0Bibtex

First China Approved Rituximab Biosimilar HLX01: Pharmacokinetics, Safety and Efficacy Comparison to Reference Rituximab in the Phase 3 Diffuse Large B-Cell Lymphoma Study

Yuankai Shi,Yongping Song,Yan Qin,Qingyuan Zhang,Xiaohong Han,Xiaonan Hong,Dong Wang,Xiaofeng Zeng,Pei Hu, Shuiyu Zhao, Kaka Y. Hong,Chaoming Ma,Jiancheng Cheng, Peng Ting, Kevin Li,Weidong Jiang,Scott Liu,Eugene Liu,Xin Zhang,Katherine Chai, Dan Yao,Alvin Y. Luk

BLOOD（2019）

Cited3Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn